StockWatch
·
Biotechnology: Pharmaceutical Preparations
ShareholdingMay 8, 2026, 04:23 PM

Genmab: Orbis Investment Management Discloses 5.08% Stake

AI Summary

Genmab A/S announced that Orbis Investment Management Limited has become a major shareholder, controlling 5.08% of the company's share capital and voting rights as of May 8, 2026. This stake amounts to 3,166,357 shares. The disclosure indicates an increase from a previously reported position of 4.8471% voting rights.

Key Highlights

  • Orbis Investment Management Limited now controls 5.08% of Genmab A/S's share capital and voting rights.
  • This represents 3,166,357 shares in Genmab A/S.
  • The threshold was crossed on May 8, 2026.
  • Previous notification indicated a 4.8471% voting rights position.